Transcription of A RANDOMIZED, DOUBLE-BLIND, PLACEBO …
{{id}} {{{paragraph}}}
Example: stock market
A RANDOMIZED, DOUBLE-BLIND, PLACEBO …
CLINICAL PROTOCOLPHASE IIIA RANDOMIZED, double - blind , PLACEBO - controlled , MULTICENTERTRIAL OF THE SAFETY AND EFFICACY OF ceftriaxone ANDDOXYCYCLINE IN thetreatment OF PATIENTS WITHSEROPOSITIVECHRONIC LYME DISEASEI nvestigators:Mark S. Klempner, , Principal InvestigatorLinden Hu, Schmid, Brown, Kaplan, C. Steere, Weinstein, R. Wormser, Danon, Dornbush, Nowakowski, Cavaliere, England Medical CenterNew York Medical CollegeClinical Studies of Chronic Lyme DiseaseNIH/NIAID Contract No. N01-AI-65308 Version OF AND STUDY AND and Exclusion Evaluation Number During Dosing treatment OF INTERCURRENT of from the protocol for the Individual Patient2829 New England Medical CenterNew York Medical CollegeClinical Studies of Chronic Lyme DiseaseNIH/NIAID Contract No. N01-AI-65308 Version EVALUATION OF EFFICACY AND REPORT OF INFORMATION AND PUBLICATION1213 XIII. COMPLETION OF STUDY14 New England Medical CenterNew York Medical CollegeClinical Studies of Chronic Lyme DiseaseNIH/NIAID Contract No.
clinical protocol phase iii a randomized, double-blind, placebo-controlled, multicenter trial of the safety and efficacy of ceftriaxone and doxycycline in thetreatment of patients with
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document: